147 related articles for article (PubMed ID: 8996276)
1. Stevens-Johnson syndrome associated with topical nitrogen mustard therapy.
Newman JM; Rindler JM; Bergfeld WF; Brydon JK
J Am Acad Dermatol; 1997 Jan; 36(1):112-4. PubMed ID: 8996276
[No Abstract] [Full Text] [Related]
2. Clinical potential of mechlorethamine gel for the topical treatment of mycosis fungoides-type cutaneous T-cell lymphoma: a review on current efficacy and safety data.
Liner K; Brown C; McGirt LY
Drug Des Devel Ther; 2018; 12():241-254. PubMed ID: 29440874
[TBL] [Abstract][Full Text] [Related]
3. Topical chemotherapy in cutaneous T-cell lymphoma: positive results of a randomized, controlled, multicenter trial testing the efficacy and safety of a novel mechlorethamine, 0.02%, gel in mycosis fungoides.
Lessin SR; Duvic M; Guitart J; Pandya AG; Strober BE; Olsen EA; Hull CM; Knobler EH; Rook AH; Kim EJ; Naylor MF; Adelson DM; Kimball AB; Wood GS; Sundram U; Wu H; Kim YH
JAMA Dermatol; 2013 Jan; 149(1):25-32. PubMed ID: 23069814
[TBL] [Abstract][Full Text] [Related]
4. Real-world experience with mechlorethamine gel in patients with mycosis fungoides-cutaneous lymphoma: Preliminary findings from a prospective observational study.
Kim EJ; Geskin L; Guitart J; Querfeld C; Girardi M; Musiek A; Mink DR; Williams MJ; Angello JT; Bailey WL
J Am Acad Dermatol; 2020 Sep; 83(3):928-930. PubMed ID: 32089294
[No Abstract] [Full Text] [Related]
5. Nitrogen mustard gel-induced inflammation triggers lymphomatoid papulosis in patients with mycosis fungoides.
Trager MH; Chen C; Husain S; Geskin LJ
J Dermatol; 2020 May; 47(5):546-550. PubMed ID: 32100361
[TBL] [Abstract][Full Text] [Related]
6. Treatment of early-stage mycosis fungoides with twice-weekly applications of mechlorethamine and topical corticosteroids: a prospective study.
de Quatrebarbes J; Estève E; Bagot M; Bernard P; Beylot-Barry M; Delaunay M; D'Incan M; Souteyrand P; Vaillant L; Cordel N; Courville P; Joly P
Arch Dermatol; 2005 Sep; 141(9):1117-20. PubMed ID: 16172308
[TBL] [Abstract][Full Text] [Related]
7. Mechlorethamine gel for the topical treatment of stage IA and IB mycosis fungoides-type cutaneous T-cell lymphoma.
Talpur R; Venkatarajan S; Duvic M
Expert Rev Clin Pharmacol; 2014 Sep; 7(5):591-7. PubMed ID: 25068889
[TBL] [Abstract][Full Text] [Related]
8. Nitrogen mustard revisited.
Knobler R
Br J Dermatol; 2014 Mar; 170(3):495. PubMed ID: 24617430
[No Abstract] [Full Text] [Related]
9. A prospective study of cutaneous intolerance to topical mechlorethamine therapy in patients with cutaneous T-cell lymphomas. French Study Group of Cutaneous Lymphomas.
Estève E; Bagot M; Joly P; Souteyrand P; Beylot-Barry M; Vaillant L; Delaunay M; Avril MF; Laroche L; Grange F; Thomine E; Wechsler J
Arch Dermatol; 1999 Nov; 135(11):1349-53. PubMed ID: 10566833
[TBL] [Abstract][Full Text] [Related]
10. [Mycosis fungoides and infantile xanthogranuloma treated with topical flupamesone].
Pereiro Miguens M
Actas Dermosifiliogr; 1977; 68(12):83-90. PubMed ID: 404849
[No Abstract] [Full Text] [Related]
11. The PROVe Study: US Real-World Experience with Chlormethine/Mechlorethamine Gel in Combination with Other Therapies for Patients with Mycosis Fungoides Cutaneous T-Cell Lymphoma.
Kim EJ; Guitart J; Querfeld C; Girardi M; Musiek A; Akilov OE; Angello JT; Bailey WL; Geskin LJ
Am J Clin Dermatol; 2021 May; 22(3):407-414. PubMed ID: 33656660
[TBL] [Abstract][Full Text] [Related]
12. Combination topical nitrogen mustard and photochemotherapy for mycosis fungoides.
Monk BE; Vollum DI; du Vivier AW
Clin Exp Dermatol; 1984 May; 9(3):243-7. PubMed ID: 6733953
[No Abstract] [Full Text] [Related]
13. In brief: mechlorethamine gel (Valchlor) for cutaneous T-Cell lymphoma.
Med Lett Drugs Ther; 2015 Apr; 57(1467):e66. PubMed ID: 25988964
[No Abstract] [Full Text] [Related]
14. [Modern therapy of mycosis fungoides].
Roenigk HH
Hautarzt; 1983 Jun; 34(6):266-72. PubMed ID: 6874333
[TBL] [Abstract][Full Text] [Related]
15. Second cutaneous malignancies in patients with mycosis fungoides treated with topical nitrogen mustard.
Lee LA; Fritz KA; Golitz L; Fritz TJ; Weston WL
J Am Acad Dermatol; 1982 Nov; 7(5):590-8. PubMed ID: 7142467
[TBL] [Abstract][Full Text] [Related]
16. Secondary cancers, comorbidities and mortality associated with nitrogen mustard therapy in patients with mycosis fungoides: a 30-year population-based cohort study.
Lindahl LM; Fenger-Grøn M; Iversen L
Br J Dermatol; 2014 Mar; 170(3):699-704. PubMed ID: 24024659
[TBL] [Abstract][Full Text] [Related]
17. Topical chemotherapy of mycosis fungoides.
Grekin DA; Zackheim HS; Epstein EH
Cutis; 1979 Nov; 24(5):543-6. PubMed ID: 520032
[TBL] [Abstract][Full Text] [Related]
18. Mycosis fungoides, nitrogen mustard and skin cancer.
Du Vivier A; Vonderheid EC; Van Scott EJ; Urbach F
Br J Dermatol; 1978 Jul; 99(1):61-3. PubMed ID: 678466
[TBL] [Abstract][Full Text] [Related]
19. Precautions for personnel applying topical nitrogen mustard to patients with mycosis fungoides.
Thestrup-Pedersen K; Christiansen JV; Zachariae H
Dermatologica; 1982 Aug; 165(2):108-13. PubMed ID: 7141061
[TBL] [Abstract][Full Text] [Related]
20. Topical Carmustine as Monotherapy or as Multimodality Therapy for Folliculotropic Mycosis Fungoides.
MacArthur KM; Jariwala N; Kim EJ; Rook AH
Acta Derm Venereol; 2017 Mar; 97(3):373-374. PubMed ID: 27868149
[No Abstract] [Full Text] [Related]
[Next] [New Search]